Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1
Authors
Keywords
Phosphorylation, Immunoprecipitation, Tyrosine, Coated pits, Actins, Adipocyte differentiation, Tyrosine kinases, Reactive oxygen species
Journal
PLoS One
Volume 8, Issue 3, Pages e58100
Publisher
Public Library of Science (PLoS)
Online
2013-03-06
DOI
10.1371/journal.pone.0058100
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trends in advanced glycation end products research in diabetes mellitus and its complications
- (2010) José D. Méndez et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- PPARγ: a circadian transcription factor in adipogenesis and osteogenesis
- (2010) Masanobu Kawai et al. Nature Reviews Endocrinology
- Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cellsThis article is one of a selection of papers published in a special issue on Advances in Cardiovascular Research.
- (2009) Ali Bouallegue et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- RAGE signaling in inflammation and arterial aging
- (2009) Li Lin Frontiers in Bioscience-Landmark
- D 1 -Like Receptors Regulate NADPH Oxidase Activity and Subunit Expression in Lipid Raft Microdomains of Renal Proximal Tubule Cells
- (2009) Hewang Li et al. HYPERTENSION
- Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane
- (2009) Patrick Lajoie et al. JOURNAL OF CELL BIOLOGY
- Receptor for AGE (RAGE) and its ligands—cast into leading roles in diabetes and the inflammatory response
- (2009) Shi Fang Yan et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders
- (2009) Isabelle Mercier et al. LABORATORY INVESTIGATION
- Oxidative Stress and Advanced Glycation in Diabetic Nephropathy
- (2008) Melinda T. Coughlan et al. Annals of the New York Academy of Sciences
- Compartmentalization of Redox Signaling Through NADPH Oxidase–Derived ROS
- (2008) Masuko Ushio-Fukai ANTIOXIDANTS & REDOX SIGNALING
- Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix
- (2008) Fatouma Touré et al. BIOCHEMICAL JOURNAL
- In Skeletal Muscle Advanced Glycation End Products (AGEs) Inhibit Insulin Action and Induce the Formation of Multimolecular Complexes Including the Receptor for AGEs
- (2008) Angela Cassese et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of insulin receptor substrate-1 expression levels by caveolin-1
- (2008) Jia Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
- (2008) Su-Yen Goh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Crosstalk Between IGF1R and Estrogen Receptor Signaling in Breast Cancer
- (2008) Dedra H. Fagan et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells
- (2008) Richard J. Santen et al. STEROIDS
- Caveolae as Organizers of Pharmacologically Relevant Signal Transduction Molecules
- (2007) Hemal H. Patel et al. Annual Review of Pharmacology and Toxicology
- Caveolin-1 Down-Regulation Inhibits Insulin-Like Growth Factor-I Receptor Signal Transduction in H9C2 Rat Cardiomyoblasts
- (2007) Barbara Salani et al. ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started